About Encepharm
Encepharm is a company based in Gottingen (Germany) founded in 2004 was acquired by Brains On-Line in May 2016. Encepharm offers products and services including Microdialysis Services and In Vivo Efficacy Testing. Encepharm operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
- Headquarter Gottingen, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Encepharm Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Brains On-Line
(May 01, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Encepharm
Encepharm offers a comprehensive portfolio of products and services, including Microdialysis Services and In Vivo Efficacy Testing.
Measures substances in freely moving animals for neuroscience research
Conducts testing to understand CNS disease mechanisms and treatments
People of Encepharm
Unlock access to complete
Software Development Team
73 people
Leadership Team
64 people
Sales and Marketing
56 people
Human Resources and Administration
42 people
Senior Team
23 people
Product Management Team
22 people
Operations Team
21 people
Data Analysis and Operations Team
12 people
Unlock access to complete
Funding Insights of Encepharm
Detailed funding history for Encepharm
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Encepharm
Encepharm has secured backing from 1 investor. Prominent investors backing the company include Brains On-Line.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Preclinical development services for CNS disorders and compounds are provided.
|
Locked | Locked | Locked |
Investor details for Encepharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Encepharm
Investment portfolio details for Encepharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Encepharm
Detailed financials for Encepharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Encepharm Comparisons
Peer comparison for Encepharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Encepharm
Encepharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| Locked | Locked | Locked |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| Locked | Locked | Locked |
Animal models are supplied for in-vivo analytical services.
|
|
| Locked | Locked | Locked |
Preclinical contract research organization offering standard GLP and non-GLP services
|
Detailed competitors of Encepharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Encepharm
Complete news archive for Encepharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Encepharm
Encepharm was founded in 2004.
Encepharm is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.
Encepharm, a spinoff of the German Primate Center (DPZ), offers preclinical RD support services such as pharmacology, ADMEPK, safety testing, behavioral, bioanalytical and histological analysis, target identification and validation and consulting services. They have experience in disease areas such as psychiatric, neurodegenerative and neuroinflammatory, metabolic and respiratory diseases and also in eating disorders. They have access to techniques such as MRI, SPECT, confocal laser microscopy, three-dimensional anatomical mapping through their collaborations with German Primate Center (DPZ), the Medical School University of Göttingen, Max Planck-Institutes, and the Fraunhofer Institute for Toxicology and Experimental Medicine in Hanover.They are AAALAC accredited and can work with both small molecules and biologics.
Encepharm's top competitors include GenOway, PsychoGenics and Alpha Genesis.
Encepharm offers Microdialysis Services and In Vivo Efficacy Testing.
Encepharm has 1 investor. Key investors include Brains On-Line.